{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:01:27Z","timestamp":1768258887780,"version":"3.49.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11154-019-09530-y","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T02:02:45Z","timestamp":1580090565000},"page":"225-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fertility issues in aggressive pituitary tumors"],"prefix":"10.1007","volume":"21","author":[{"given":"J\u00falia Vieira Oberger","family":"Marques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar Luiz","family":"Boguszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"issue":"2","key":"9530_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10143-014-0525-y","volume":"37","author":"TM Hansen","year":"2014","unstructured":"Hansen TM, Batra S, Lim M, Gallia GL, Burger PC, Salvatori R, et al. Invasive adenoma and pituitary carcinoma: a SEER database analysis. Neurosurg Rev. 2014;37(2):279\u201385 discussion 285-6.","journal-title":"Neurosurg Rev"},{"issue":"Grade III","key":"9530_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","volume":"96","author":"BP Meij","year":"2002","unstructured":"Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg. 2002;96(Grade III):195\u2013208.","journal-title":"J Neurosurg"},{"key":"9530_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol. 2017;28:228\u201343.","journal-title":"Endocr Pathol"},{"key":"9530_CR4","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, et al. European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2018;178:G1\u2013G24.","journal-title":"Eur J Endocrinol"},{"key":"9530_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-17-0933","volume":"178","author":"A McCormack","year":"2018","unstructured":"McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, et al. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. Eur J Endocrinol. 2018;178:265\u201376.","journal-title":"Eur J Endocrinol"},{"key":"9530_CR6","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1210\/jcem.83.12.5300","volume":"83","author":"GA Kaltsas","year":"1998","unstructured":"Kaltsas GA, Mukherjee JJ, Plowman PN, Monson JP, Grossman AB, Besser GM. The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors. J Clin Endocrinol Metab. 1998;83:4233\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"9530_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11060-015-1991-y","volume":"126","author":"M Losa","year":"2016","unstructured":"Losa M, Bogazzi F, Cannavo S, Ceccato F, Curto L, De Marinis L, et al. Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas. J Neuro-Oncol. 2016;126:519\u201325.","journal-title":"J Neuro-Oncol"},{"key":"9530_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1530\/EJE-16-0979","volume":"176","author":"H Lasolle","year":"2017","unstructured":"Lasolle H, Cortet C, Castinetti F, Cloix L, Caron P, Delemer B, et al. Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas. Eur J Endocrinol. 2017;176:769\u201377.","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 9","key":"9530_CR9","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1586\/14737140.6.9s.S55","volume":"6","author":"J Hirshfeld-Cytron","year":"2006","unstructured":"Hirshfeld-Cytron J, Kim HH. Treatment of infertility in women with pituitary tumors. Expert Rev Anticancer Ther. 2006;6(Suppl 9):S55\u201362.","journal-title":"Expert Rev Anticancer Ther"},{"key":"9530_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev. 2006;27:485\u2013534.","journal-title":"Endocr Rev"},{"key":"9530_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.20945\/2359-3997000000032","volume":"62","author":"L Vilar","year":"2018","unstructured":"Vilar L, Abucham J, Albuquerque JL, Araujo LA, Azevedo MF, Boguszewski CL, et al. Controversial issues in the management of hyperprolactinemia and prolactinomas: an overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Arch Endocrinol Metab. 2018;62:236\u201363.","journal-title":"Arch Endocrinol Metab"},{"key":"9530_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273\u201388.","journal-title":"J Clin Endocrinol Metab"},{"key":"9530_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/cen.12242","volume":"79","author":"AB Moraes","year":"2013","unstructured":"Moraes AB, Silva CM, Vieira Neto L, Gadelha MR. Giant prolactinomas: the therapeutic approach. Clin Endocrinol. 2013;79:447\u201356.","journal-title":"Clin Endocrinol"},{"key":"9530_CR14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.23736\/S0391-1977.17.02792-4","volume":"43","author":"A Glezer","year":"2018","unstructured":"Glezer A, Bronstein MD. Prolactinomas: how to handle prior to and during pregnancy? Minerva Endocrinol. 2018;43:423\u20139.","journal-title":"Minerva Endocrinol"},{"key":"9530_CR15","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1172\/JCI63937","volume":"122","author":"C Sonigo","year":"2012","unstructured":"Sonigo C, Bouilly J, Carr\u00e9 N, Tolle V, Caraty A, Tello J, et al. Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J Clin Invest. 2012;122:3791\u20135.","journal-title":"J Clin Invest"},{"key":"9530_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s12020-015-0791-7","volume":"52","author":"E Espinosa","year":"2016","unstructured":"Espinosa E, Sosa E, Mendoza V, Ram\u00edrez C, Melgar V, Mercado M. Giant prolactinomas: are they really different from ordinary macroprolactinomas? Endocrine. 2016;52:652\u20139.","journal-title":"Endocrine"},{"key":"9530_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11102-010-0290-z","volume":"14","author":"V dos Santos Nunes","year":"2011","unstructured":"dos Santos Nunes V, El Dib R, Boguszewski CL, Nogueira CR. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis. Pituitary. 2011;14:259\u201365.","journal-title":"Pituitary"},{"key":"9530_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40618-013-0019-8","volume":"37","author":"R Pivonello","year":"2014","unstructured":"Pivonello R, De Martino MC, Auriemma RS, Alviggi C, Grasso LF, Cozzolino A, et al. Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. J Endocrinol Investig. 2014;37:99\u2013112.","journal-title":"J Endocrinol Investig"},{"key":"9530_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","volume":"117","author":"ME Molitch","year":"2014","unstructured":"Molitch ME. Management of medically refractory prolactinoma. J Neuro-Oncol. 2014;117:421\u20138.","journal-title":"J Neuro-Oncol"},{"key":"9530_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000371806","volume":"101","author":"E Chatzellis","year":"2015","unstructured":"Chatzellis E, Alexandraki KI, Androulakis II, Kaltsas G. Aggressive pituitary tumors. Neuroendocrinology. 2015;101:87\u2013104.","journal-title":"Neuroendocrinology"},{"key":"9530_CR21","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1210\/jc.2009-2605","volume":"95","author":"M Ono","year":"2010","unstructured":"Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab. 2010;95:2672\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"9530_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clineuro.2018.11.024","volume":"176","author":"N Lamba","year":"2019","unstructured":"Lamba N, Noormohamed N, Simjian T, Alsheikh MY, Jamal A, Doucette J, et al. Fertility after transsphenoidal surgery in patients with prolactinomas: a meta-analysis. Clin Neurol Neurosurg. 2019;176:53\u201360.","journal-title":"Clin Neurol Neurosurg"},{"key":"9530_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1227\/01.NEU.0000223445.22938.BD","volume":"59","author":"N Pouratian","year":"2006","unstructured":"Pouratian N, Sheehan J, Jagannathan J, Laws ER, Steiner L, Vance ML. Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery. 2006;59:255\u201364.","journal-title":"Neurosurgery"},{"key":"9530_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.crwh.2015.09.001","volume":"8","author":"A Espinosa De Ycaza","year":"2015","unstructured":"Espinosa De Ycaza A, Chang AY, Jensen JR, Khan Z, Erickson D. Approach to the management of rare clinical presentations of macroprolactinomas in reproductive-aged women. Case Rep Womens Health. 2015;8:9\u201312.","journal-title":"Case Rep Womens Health"},{"key":"9530_CR25","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.18203\/2320-1770.ijrcog20150775","volume":"4","author":"N Pushpagiri","year":"2015","unstructured":"Pushpagiri N, Manam G. Management of resistant prolactinoma in infertile lady with successful maternal and perinatal outcome. Int J Reprod Contraception, Obstet Gynecol. 2015;4:1659\u201362.","journal-title":"Int J Reprod Contraception, Obstet Gynecol"},{"key":"9530_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-09-0084","volume":"161","author":"RS Ribeiro","year":"2009","unstructured":"Ribeiro RS, Abucham J. Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment. Eur J Endocrinol. 2009;161:163\u20139.","journal-title":"Eur J Endocrinol"},{"key":"9530_CR27","doi-asserted-by":"crossref","unstructured":"Raverot G, Vasiljevic A, Jouanneau E, Lasolle H. Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma \u2013 commentary. Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0359.","DOI":"10.1530\/EJE-19-0359"},{"key":"9530_CR28","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1210\/jc.2009-2815","volume":"95","author":"M Grynberg","year":"2010","unstructured":"Grynberg M, Salenave S, Young J, Chanson P. Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab. 2010;95:4518\u201325.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9530_CR29","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-16-1059","volume":"177","author":"J Abucham","year":"2017","unstructured":"Abucham J, Bronstein MD, Dias ML. MANAGEMENT OF ENDOCRINE DISEASE: acromegaly and pregnancy: a contemporary review. Eur J Endocrinol. 2017;177(1):R1\u2013R12.","journal-title":"Eur J Endocrinol"},{"key":"9530_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ghir.2016.10.004","volume":"30\u201331","author":"L Rostomyan","year":"2016","unstructured":"Rostomyan L, Beckers A. Screening for genetic causes of growth hormone hypersecretion. Growth Horm IGF Res. 2016;30\u201331:52\u20137.","journal-title":"Growth Horm IGF Res"},{"key":"9530_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrendo.2014.21","volume":"10","author":"A Giustina","year":"2014","unstructured":"Giustina A, Chanson P, Kleinberg D, Bronstein MD, Clemmons DR, Klibanski A, et al. Acromegaly Consensus Group Expert consensus document: a consensus on the medical treatment of acromegaly. Nat Rev Endocrinol. 2014;10:243\u20138.","journal-title":"Nat Rev Endocrinol"},{"key":"9530_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/1871530318666180807160712","volume":"19","author":"F Dicuonzo","year":"2019","unstructured":"Dicuonzo F, Purciariello S, De Marco A, Guastamacchia E, Triggiani V. Inoperable giant growth hormone-secreting pituitary adenoma: radiological aspects, clinical management and pregnancy outcome. Endocr Metab Immune Disord Drug Targets. 2019;19:214\u201320.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"11\u201312","key":"9530_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10815-006-9077-6","volume":"23","author":"A Qureshi","year":"2006","unstructured":"Qureshi A, Kalu E, Ramanathan G, Bano G, Croucher C, Panahloo A. IVF\/ICSI in a woman with active acromegaly: successful outcome following treatment with pegvisomant. J Assist Reprod Genet. 2006;23(11\u201312):439\u201342.","journal-title":"J Assist Reprod Genet"},{"key":"9530_CR34","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.fertnstert.2004.10.034","volume":"83","author":"N Esfandiari","year":"2005","unstructured":"Esfandiari N, Gotlieb L, Casper RF. Live birth of healthy triplets after in vitro fertilization and embryo transfer in an acromegalic woman with elevated growth hormone. Fertil Steril. 2005;83:1041.","journal-title":"Fertil Steril"},{"key":"9530_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-13-0460","volume":"170","author":"M Dias","year":"2013","unstructured":"Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, et al. Acromegaly and pregnancy: a prospective study. Eur J Endocrinol. 2013;170:301\u201310.","journal-title":"Eur J Endocrinol"},{"key":"9530_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11102-016-0740-3","volume":"20","author":"A Muhammad","year":"2017","unstructured":"Muhammad A, Neggers SJ, van der Lely AJ. Pregnancy and acromegaly. Pituitary. 2017;20:179\u201384.","journal-title":"Pituitary"},{"key":"9530_CR37","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1210\/jc.2009-2331","volume":"95","author":"P Caron","year":"2010","unstructured":"Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, et al. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 2010;95:4680\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"9530_CR38","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1210\/jc.2014-3913","volume":"100","author":"FH Duarte","year":"2015","unstructured":"Duarte FH, Jallad RS, Bronstein MD. Clomiphene citrate for treatment of acromegaly not controlled by conventional therapies. J Clin Endocrinol Metab. 2015;100:1863\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"9530_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0090-4295(87)90598-X","volume":"29","author":"T Usui","year":"1987","unstructured":"Usui T, Ishibe T, Matsumoto S. HCG and HMG treatment of male infertility with pituitary problems. Urology. 1987;29:50\u20133.","journal-title":"Urology"},{"key":"9530_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fendo.2019.00322","volume":"10","author":"HM Behre","year":"2019","unstructured":"Behre HM. Clinical use of FSH in male infertility. Front Endocrinol (Lausanne). 2019;10:322.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9530_CR41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.beem.2011.08.001","volume":"25","author":"D Unuane","year":"2011","unstructured":"Unuane D, Tournaye H, Velkeniers B, Poppe K. Endocrine disorders and female infertility. Best Pract Res Clin Endocrinol Metab. 2011;25:861\u201373.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9530_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol. 2016;4:611\u201329.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9530_CR43","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1210\/jc.2004-2361","volume":"90","author":"JR Lindsay","year":"2005","unstructured":"Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK. Cushing\u2019s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab. 2005;90:3077\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"9530_CR44","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1308\/rcsann.2018.0175","volume":"101","author":"K Jolly","year":"2019","unstructured":"Jolly K, Darr A, Arlt W, Ahmed S, Karavitaki N. Surgery for Cushing\u2019s disease in pregnancy: our experience and a literature review. Ann R Coll Surg Engl. 2019;101:e26\u201331.","journal-title":"Ann R Coll Surg Engl"},{"key":"9530_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12020-016-1117-0","volume":"55","author":"F Caimari","year":"2017","unstructured":"Caimari F, Valassi E, Garbayo P, Steffensen C, Santos A, Corcoy R, et al. Cushing\u2019s syndrome and pregnancy outcomes: a systematic review of published cases. Endocrine. 2017;55:555\u201363.","journal-title":"Endocrine"},{"key":"9530_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-017-1458-3","volume":"59","author":"P Mortini","year":"2018","unstructured":"Mortini P, Barzaghi LR, Albano L, Panni P, Losa M. Microsurgical therapy of pituitary adenomas. Endocrine. 2018;59:72\u201381.","journal-title":"Endocrine"},{"issue":"3","key":"9530_CR47","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1210\/jc.2018-02080","volume":"104","author":"M Theodoropoulou","year":"2019","unstructured":"Theodoropoulou M, Reincke M. Tumor-directed therapeutic targets in Cushing disease. J Clin Endocrinol Metab. 2019;104(3):925\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"9530_CR48","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1210\/jc.2012-3200","volume":"98","author":"X Bertagna","year":"2013","unstructured":"Bertagna X, Guignat L. Approach to the Cushing\u2019s disease patient with persistent\/recurrent hypercortisolism after pituitary surgery. J Clin Endocrinol Metab. 2013;98:1307\u201318.","journal-title":"J Clin Endocrinol Metab"},{"key":"9530_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00701-003-0174-3","volume":"146","author":"P Nomikos","year":"2004","unstructured":"Nomikos P, Ladar C, Fahlbusch R, Buchfelder M. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas: a study on 721 patients. Acta Neurochir. 2004;146:27\u201335.","journal-title":"Acta Neurochir"},{"key":"9530_CR50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317:516\u201324.","journal-title":"JAMA"},{"key":"9530_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11102-018-0868-4","volume":"21","author":"G Minniti","year":"2018","unstructured":"Minniti G, Flickinger J, Tolu B, Paolini S. Management of nonfunctioning pituitary tumors: radiotherapy. Pituitary. 2018;21:154\u201361.","journal-title":"Pituitary"},{"key":"9530_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/AOG.0000000000001747","volume":"129","author":"K Lambert","year":"2017","unstructured":"Lambert K, Rees K, Seed PT, Dhanjal MK, Knight M, McCance DR, et al. Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes. Obstet Gynecol. 2017;129:185\u201394.","journal-title":"Obstet Gynecol"},{"key":"9530_CR53","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1210\/js.2017-00005","volume":"1","author":"FA Correa","year":"2017","unstructured":"Correa FA, Bianchi PHM, Franca MM, Otto AP, Rodrigues RJM, Ejzenberg D, et al. Successful pregnancies after adequate hormonal replacement in patients with combined pituitary hormone deficiencies. J Endocr Soc. 2017;1:1322\u201330.","journal-title":"J Endocr Soc"},{"key":"9530_CR54","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12020-016-0863-3","volume":"52","author":"FG Amlashi","year":"2016","unstructured":"Amlashi FG, Tritos NA. Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management. Endocrine. 2016;52:427\u201340.","journal-title":"Endocrine"},{"key":"9530_CR55","doi-asserted-by":"publisher","first-page":"e9546","DOI":"10.1097\/MD.0000000000009546","volume":"97","author":"J Li","year":"2018","unstructured":"Li J, Li J, Jiang S, Yu R, Yu Y. Case report of a pituitary thyrotropin-secreting macroadenoma with Hashimoto thyroiditis and infertility. Medicine (Baltimore). 2018;97:e9546.","journal-title":"Medicine (Baltimore)"},{"key":"9530_CR56","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/09513590.2016.1260110","volume":"33","author":"CM Perdomo","year":"2017","unstructured":"Perdomo CM, \u00c1rabe JA, Idoate M\u00c1, Galofr\u00e9 JC. Management of a pregnant woman with thyrotropinoma: a case report and review of the literature. Gynecol Endocrinol. 2017;33:188\u201392.","journal-title":"Gynecol Endocrinol"},{"key":"9530_CR57","doi-asserted-by":"crossref","unstructured":"Ilie MD, Lasolle H, Raverot G. Emerging and novel treatments for pituitary tumors. J Clin Med. 2019;8(8).","DOI":"10.3390\/jcm8081107"},{"key":"9530_CR58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1078155212469243","volume":"19","author":"RE Strowd","year":"2013","unstructured":"Strowd RE, Blackwood R, Brown M, Harmon M, Lovato J, Yalcinkaya T, et al. Impact of temozolomide on gonadal function in patients with primary malignant brain tumors. J Oncol Pharm Pract. 2013;19:321\u20137.","journal-title":"J Oncol Pharm Pract"},{"issue":"9 Suppl","key":"9530_CR59","first-page":"71","volume":"31","author":"D Milardi","year":"2008","unstructured":"Milardi D, Giampietro A, Baldelli R, Pontecorvi A, De Marinis L. Fertility and hypopituitarism. J Endocrinol Investig. 2008;31(9 Suppl):71\u20134.","journal-title":"J Endocrinol Investig"},{"key":"9530_CR60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0794-7587","volume":"79","author":"S Petersenn","year":"2019","unstructured":"Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, et al. Pituitary disease in pregnancy: special aspects of diagnosis and treatment? Geburtshilfe Frauenheilkd. 2019;79:365\u201374.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"9530_CR61","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ghir.2015.06.006","volume":"25","author":"K Stochholm","year":"2015","unstructured":"Stochholm K, Johannsson G. Reviewing the safety of GH replacement therapy in adults. Growth Hormon IGF Res. 2015;25:149\u201357.","journal-title":"Growth Hormon IGF Res"},{"key":"9530_CR62","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/er.2018-00166","volume":"40","author":"CL Boguszewski","year":"2019","unstructured":"Boguszewski CL, Boguszewski MCS. Growth Hormone\u2019s links to cancer. Endocr Rev. 2019;40:558\u201374.","journal-title":"Endocr Rev"},{"key":"9530_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/andr.12128","volume":"4","author":"J Rohayem","year":"2016","unstructured":"Rohayem J, Sinthofen N, Nieschlag E. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults. Andrology. 2016;4:87\u201394.","journal-title":"Andrology"},{"key":"9530_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ando.2012.07.103","volume":"73","author":"S Trabado","year":"2012","unstructured":"Trabado S, Maione L, Brailly-Tabard S, Young J. Male acquired hypogonadotropic hypogonadism: Diagnosis and treatment. Ann Endocrinol (Paris). 2012;73:141\u20136.","journal-title":"Ann Endocrinol (Paris)"},{"key":"9530_CR65","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2164\/jandrol.107.003400","volume":"28","author":"A Chudnovsky","year":"2007","unstructured":"Chudnovsky A, Niederberger CS. Gonadotropin therapy for infertile men with hypogonadotropic hypogonadism. J Androl. 2007;28:644\u20136.","journal-title":"J Androl"},{"key":"9530_CR66","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12958-018-0432-0","volume":"16","author":"R Marci","year":"2018","unstructured":"Marci R, Mallozzi M, Di Benedetto L, Schimberni M, Mossa S, Soave I, et al. Radiations and female fertility. Reprod Biol Endocrinol. 2018;16:112.","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-019-09530-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-019-09530-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-019-09530-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T22:49:20Z","timestamp":1665614960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-019-09530-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9530"],"URL":"https:\/\/doi.org\/10.1007\/s11154-019-09530-y","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"27 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}